NEW HAVEN, Conn., March 18, 2026 (GLOBE NEWSWIRE)-- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to create a new class of drugs based on targeted protein degradation, ...
TORRANCE, CA, UNITED STATES, March 10, 2026 /EINPresswire.com/ — The new platform brings professional-grade deal analysis, renovation previews, contractor bidding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results